Under MTA


18F-DCFPyl is a fluorine-18 labelled ligand binding specifically to PSMA. Developed by Johns Hopkins University (JHU), it allows imaging of prostate cancer and clear-cell renal-cell carcinoma (CCRCC).



The preparation of 18F-DCFPyl has been implemented jointly by Trasis and JHU on the AllinOne automated synthesizer. The process uses a cassette and a reagent kit.


  • State-of-the-art yield 
  • No lab bench preparation
  • Ready for use consumables
  • Reduced operator exposure 


Cassette and reagents set up time < 1 min
Synthesis time 60 min
Radiochemical purity ≥ 95